Activation of PPARγ Attenuates Age-Related Lacrimal Gland Dysfunction by Alleviating Endoplasmic Reticulum Stress-Mediated Ferroptosis
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.5.52 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Han Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: PPAR gamma, Endoplasmic Reticulum Stress, Aging, Ferroptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
- Hunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan, People's Republic of China.
Zitieren
APA
Zhao, H., Xu, Y., Feng, P., Wang, X., Chen, B., & Zhang, L. (2026). Activation of PPARγ Attenuates Age-Related Lacrimal Gland Dysfunction by Alleviating Endoplasmic Reticulum Stress-Mediated Ferroptosis. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.52
Vancouver
Zhao H, Xu Y, Feng P, Wang X, Chen B, Zhang L. Activation of PPARγ Attenuates Age-Related Lacrimal Gland Dysfunction by Alleviating Endoplasmic Reticulum Stress-Mediated Ferroptosis. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.52
BibTeX
@article{Zhao2026,
author = {Zhao, Han and Xu, Yiming and Feng, Peiwen and Wang, Xinyue and Chen, Baihua and Zhang, Liwei},
title = {Activation of PPARγ Attenuates Age-Related Lacrimal Gland Dysfunction by Alleviating Endoplasmic Reticulum Stress-Mediated Ferroptosis},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.5.52}
}
EUVIMED